474 related articles for article (PubMed ID: 35729252)
1. Sustained effects of single doses of classical psychedelics in humans.
Knudsen GM
Neuropsychopharmacology; 2023 Jan; 48(1):145-150. PubMed ID: 35729252
[TBL] [Abstract][Full Text] [Related]
2. Towards an understanding of psychedelic-induced neuroplasticity.
Calder AE; Hasler G
Neuropsychopharmacology; 2023 Jan; 48(1):104-112. PubMed ID: 36123427
[TBL] [Abstract][Full Text] [Related]
3. Role of Psychedelics in Treatment-Resistant Depression.
Kamal S; Jha MK; Radhakrishnan R
Psychiatr Clin North Am; 2023 Jun; 46(2):291-305. PubMed ID: 37149346
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.
Dos Santos RG; Bouso JC; Alcázar-Córcoles MÁ; Hallak JEC
Expert Rev Clin Pharmacol; 2018 Sep; 11(9):889-902. PubMed ID: 30102078
[TBL] [Abstract][Full Text] [Related]
5. Psychedelia: The interplay of music and psychedelics.
Jerotic K; Vuust P; Kringelbach ML
Ann N Y Acad Sci; 2024 Jan; 1531(1):12-28. PubMed ID: 37983198
[TBL] [Abstract][Full Text] [Related]
6. Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis.
Leger RF; Unterwald EM
J Psychopharmacol; 2022 Jan; 36(1):20-30. PubMed ID: 34519567
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of psychedelics in psychiatry, a systematic review of the literature].
Berkovitch L; Roméo B; Karila L; Gaillard R; Benyamina A
Encephale; 2021 Aug; 47(4):376-387. PubMed ID: 33888297
[TBL] [Abstract][Full Text] [Related]
8. Psychedelic drugs for psychiatric disorders.
da Costa SC; Oesterle T; Rummans TA; Richelson E; Gold M
J Neurol Sci; 2022 Sep; 440():120332. PubMed ID: 35841696
[TBL] [Abstract][Full Text] [Related]
9. [Contribution of serotonin 5-HT
Ibi D
Nihon Yakurigaku Zasshi; 2023 May; 158(3):229-232. PubMed ID: 36990794
[TBL] [Abstract][Full Text] [Related]
10. The Therapeutic Potential of Psilocybin.
Lowe H; Toyang N; Steele B; Valentine H; Grant J; Ali A; Ngwa W; Gordon L
Molecules; 2021 May; 26(10):. PubMed ID: 34063505
[TBL] [Abstract][Full Text] [Related]
11. Psilocybin--summary of knowledge and new perspectives.
Tylš F; Páleníček T; Horáček J
Eur Neuropsychopharmacol; 2014 Mar; 24(3):342-56. PubMed ID: 24444771
[TBL] [Abstract][Full Text] [Related]
12. Human behavioral pharmacology of psychedelics.
Strickland JC; Johnson MW
Adv Pharmacol; 2022; 93():105-132. PubMed ID: 35341564
[TBL] [Abstract][Full Text] [Related]
13. Psychedelics and Personality.
Aixalà M; Dos Santos RG; Hallak JEC; Bouso JC
ACS Chem Neurosci; 2018 Oct; 9(10):2304-2306. PubMed ID: 29863323
[TBL] [Abstract][Full Text] [Related]
14. Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms.
Skosnik PD; Sloshower J; Safi-Aghdam H; Pathania S; Syed S; Pittman B; D'Souza DC
J Psychopharmacol; 2023 Jul; 37(7):687-697. PubMed ID: 37392016
[TBL] [Abstract][Full Text] [Related]
15. Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.
Wulff AB; Nichols CD; Thompson SM
Neuropharmacology; 2023 Jun; 231():109504. PubMed ID: 36921889
[TBL] [Abstract][Full Text] [Related]
16. Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.
Lowe H; Toyang N; Steele B; Grant J; Ali A; Gordon L; Ngwa W
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458717
[TBL] [Abstract][Full Text] [Related]
17. Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis.
Goldberg SB; Shechet B; Nicholas CR; Ng CW; Deole G; Chen Z; Raison CL
Psychol Med; 2020 Dec; 50(16):2655-2666. PubMed ID: 33143790
[TBL] [Abstract][Full Text] [Related]
18. Classical psychedelics for the treatment of depression and anxiety: A systematic review.
Muttoni S; Ardissino M; John C
J Affect Disord; 2019 Nov; 258():11-24. PubMed ID: 31382100
[TBL] [Abstract][Full Text] [Related]
19. The zebrafish for preclinical psilocybin research.
Syed OA; Tsang B; Gerlai R
Neurosci Biobehav Rev; 2023 Oct; 153():105381. PubMed ID: 37689090
[TBL] [Abstract][Full Text] [Related]
20. Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview.
Tabaac BJ; Shinozuka K; Arenas A; Beutler BD; Cherian K; Evans VD; Fasano C; Muir OS
Am J Ther; 2024 Mar-Apr 01; 31(2):e97-e103. PubMed ID: 38518266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
